A consolidated biovigilance system for blood, tissue and organs: One size does not fit all

American Journal of Transplantation

Volumn 12, Issue 5, 2012, Pages 1099-1101

  Pruett, T L ^a   Blumberg, E A ^b   Cohen, D J ^c   Crippin, J S ^d   Freeman, R B ^e   Hanto, D W ^f   Mulligan, D C ^g   Green, M D ^h  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Biovigilance; disease transmission; donor evaluation; organ donation

Indexed keywords

AWARENESS; BIOSAFETY; BLOOD SAFETY; BLOOD TRANSFUSION; CELL TRANSPLANTATION; CLINICAL PRACTICE; DEATH; DISEASE COURSE; DISEASE TRANSMISSION; FOOD AND DRUG ADMINISTRATION; GRAFT RECIPIENT; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEPATITIS B VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MORBIDITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK BENEFIT ANALYSIS; TISSUE TRANSPLANTATION;

BLOOD TRANSFUSION; HEALTH POLICY; HUMANS; ORGAN TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE TRANSPLANTATION;

EID: 84860427155     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03907.x     Document Type: Review

References (9)

1. Morris MI, Fischer SA, Ison MG,. Infections transmitted by transplantation. Infect Dis Clin North Am 2010; 24: 497-514.
2. Title 42-Public Health; Chapter I-Public Health Service, Department of Health and Human Services Subchapter K-Health Resources Development; Part 121-Organ Procurement and Transplantation Network. Available at:. Accessed March 24, 2012.
3. Biovigilance in the United States: efforts to bridge a critical gap in patient safety and donor health report. Washington D.C.: Public Health Service (PHS) Biovigilance Working Group, 2009. Available at:. Accessed March 24, 2012.
4. Whitaker BI, Green J, King MR, et al,. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington (DC): Department of Health and Human Services; 2008.
5. Ison M., Donor-derived disease transmission events in the United States in 2009, a report from the OPTN/UNOS DTAC San Diego. Am Transpl Congress 2010. Available at:. Accessed March 24, 2012.
6. Humar A, Morris M, Blumberg E, et al,. Nucleic acid testing (NAT) of organ donors: Is the "best" test the right test? A consensus conference report. Am J Transpl 2010; 10: 889-899.
7. Shafer TJ, Schkade D, Schkade L, Geier SS, Orlowski JP, Klintmalm G,. Zero risk tolerance costs lives: Loss of transplantable organs due to human immunodeficiency virus nucleic acid testing of potential donors. Prog Transplant 2011; 21: 236-245.
8. Ison MG, Green M, Covington S, et al,. Discordant testing results-Lessons learned. A report from the OPTN Ad Hoc Diseases Transmission Advisory Committee (DTAC). Infectious Diseases Society of America, Vancouver, Canada, 2010. Available at
9. Mencken HL,. The Divine Afflatus, The New York Evening Mail, 16 November 1917.